Skip to main content

Instil Bio, Inc.

TIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789769

No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Instil Bio, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of TIL: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders9995−4
Shares119.2M119.2M−18.1K (0.0%)
Value$550.9M$577.0M+$26.1M (+4.7%)

New holders (11)

Institutions that held Instil Bio, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to TIL in Q3 2022
InstitutionSharesValue% of portfolio
Wellington Management Group LLP238,434$1.15M0.00%
State of Wisconsin Investment Board59,380$287.0K0.00%
Cornercap Investment Counsel Inc42,489$206.0K0.04%
Nisa Investment Advisors, LLC20,300$89.0K0.00%
Price T Rowe Associates Inc10,835$53.0K0.00%
Federated Hermes, Inc.8,847$43.0K0.00%
China Universal Asset Management Co., Ltd.1,214$6.00K0.00%
Simplex Trading, LLC533$2.00K0.00%
UBS Group AG315$1.00K0.00%
Ellevest, Inc.166$1.00K0.00%
Community Bank, N.A.18$00.00%

Sold out (15)

Institutions that held Instil Bio, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.